165 filings
Page 4 of 9
8-K
vnzhdpaz6oqwmghj
25 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:11am
EFFECT
cgw8p8 f3p6
21 Nov 22
Notice of effectiveness
12:15am
CORRESP
whvu1p0ut8 9msxk
17 Nov 22
Correspondence with SEC
12:00am
CORRESP
hqcnesktz 31hc664
16 Nov 22
Correspondence with SEC
12:00am
UPLOAD
5geahxu22huy ifqfd11
14 Nov 22
Letter from SEC
12:00am
8-K
avwrd u2awis
10 Nov 22
Results of Operations and Financial Condition
5:00pm
8-K
wec 0k4q8rthhgjv2cv
25 Oct 22
Revelation Biosciences Inc. Announces Positive Results in Preclinical Model
4:01pm
8-K
sy5wtvn39 0rt
6 Oct 22
Developing innovative therapeutics to address unmet needs Corporate Presentation / October 2022 www.revbiosciences.com
4:02pm
8-K
8sbi46a djtiq4s6j
17 Aug 22
Results of Operations and Financial Condition
4:32pm
8-K
iyuhxq7h23 secd5ox
1 Aug 22
Revelation Biosciences Inc. Announces Pricing of $5 Million Public Offering
5:09pm
424B3
mfatov
27 Jul 22
Prospectus supplement
4:46pm
EFFECT
cl6s73 af8tyzjqrc5
26 Jul 22
Notice of effectiveness
12:15am
CORRESP
0dca5aiyw rhu
25 Jul 22
Correspondence with SEC
12:00am